Global Trade Alert
Global Trade Alert

Back to state act

United States of America: BARDA provides $85.3 million funding to Janssen Pharmaceuticals to support Janssen’s COVID-19 vaccine phase 2 clinical trials and additional non-clinical studies

Description

On 21 August 2020, the U.S. Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA) announced providing USD 85.3 million funding to Janssen Pharma...

Sign in to see full description

Intervention Details

Intervention Type

State aid, unspecified

MAST Chapter

L: Subsidies (excl. export subsidies)

Implementation date

21 Aug 2020

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 1 products

Threads

See all

This intervention is not part of any Thread yet.